Table 1.
EV type | Recipient cell type | Functional effect or interaction |
---|---|---|
Oligodendrocyte EVs (Oli-Neu EVs) |
- Mixed primary and mono primary cultures C3cr1/ EGFP labeled |
Robust and specific uptake [38, 41] PS-dependent specific uptake into microglia [38] No change in morphology or cytokine expression [38] |
Neuroblastoma EVs (N2a EVs) |
Primary microglia BV2 mouse microglial line |
Specific uptake into microglia and not primary neuronal cells [39] Colocalization in vivo with 93% of IBA1 positive microglia at P2 and 80% at P7 [38] |
Astrocyte derived EVs (ADEVs) | Primary microglia |
Internalized by microglia and trafficked to microglial endosomes [40]. Decreased microglial phagocytosis following morphine – exposed ADEV treatment [40]. |
Subventricular zone neural stem cell- derived extracellular vesicles (SVZ NSC) EVs | In vivo microglia |
Uptake into IBA1 and CD11b positive microglia [43]. Increase in CD11b expression and transition to rounded less complex cells [43]. |
Pheochromocytoma EVs (PC12 EVs) | MG6 mouse microglial line |
Enhanced ability of microglia to remove degenerating neurite from PC12 cells due to upregulation of complement component 3 (C3). [42]. No effect on phagocytosis of E Coli [42]. |
Murine lymphoblast EVs (EL-4) | In vivo IB11+ microglia | Colocalization with greater than 60% of IBA1+ cells after intranasal administration [44] |